<DOC>
	<DOCNO>NCT01342120</DOCNO>
	<brief_summary>The purpose observational study study specific outcomes interest user quetiapine compare atypical antipsychotic specifically olanzapine risperidone . The outcomes interest all-cause mortality , fail suicide attempt , extrapyramidal symptom , diabetes mellitus , hypothyroidism , acute myocardial infarction stroke . This retrospective cohort study base population-based record linkage system ( PHARMO RLS ) capture 2.5 million resident Netherlands .</brief_summary>
	<brief_title>PHARMO Institute Seroquel Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Episode new use atypical antipsychotic na√Øve ( use antipsychotic drug year ) user antipsychotic . less year record history cohort entry date use multiple antipsychotic concomitantly duration dose antipsychotic drug determine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>atypical antipsychotic</keyword>
	<keyword>quetiapine</keyword>
</DOC>